Active substanceHydrochlorothiazide + IrbesartanHydrochlorothiazide + Irbesartan
Dosage form: & nbspFilm-coated tablets.
Pharmacotherapeutic group:hypotensive combined agent (angiotensin II receptor antagonist [ARA II] + diuretic).
ATX: & nbsp

C.09.D.A.04   Irbesartan in combination with diuretics

C.09.D.A   Angiotensin II antagonists in combination with diuretics

Form release / dosage:Tablets, film-coated 12.5 mg + 150 mg, 12.5 mg + 300 mg, 25 mg + 300 mg.
Packaging:
  • (10) - blister (3) / 3 blisters together with instructions for use in a pack of cardboard / - Pack of cardboard
  • (14) - blister (2) / 2 blisters together with instructions for use in a pack of cardboard / - Pack of cardboard
  • (15) - blister (2) / 2 blisters together with instructions for use in a pack of cardboard / - Pack of cardboard
  • (7) - blister (4) / 4 blisters together with instructions for use in a pack of cardboard / - Pack of cardboard
Storage conditions:Storage conditions: At a temperature not exceeding 25 ° C.Keep out of the reach of children.
Shelf life:2 years.
Terms of leave from pharmacies:On prescription
Registration number:LP-001737
Date of registration:02.07.2012
Date of cancellation:2017-07-02
The owner of the registration certificate:Pharmaceutical factory "POLFARMA" JSCPharmaceutical factory "POLFARMA" JSC Poland
Information update date: & nbsp20.12.2015
Illustrated instructions
    Instructions
    Up